Optiver Holding’s AbbVie ABBV Stock Holding History

Optiver Holding’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93.1K	Sell	370 -2,065	-85%	-$444K	﹤0.01%	1044
2026 Q1	$530K	Buy	+2,435	New	+$540K	﹤0.01%	643
2025 Q4	–	Sell	-2,027	Closed	-$469K	–	2441
2025 Q3	$469K	Buy	+2,027	New	+$413K	﹤0.01%	530
2025 Q1	–	Sell	-1,534	Closed	-$273K	–	1323
2024 Q4	$273K	Buy	1,534 +643	+72%	+$118K	﹤0.01%	460
2024 Q3	$176K	Sell	891 -2,568	-74%	-$479K	﹤0.01%	467
2024 Q2	$593K	Buy	3,459 +2,540	+276%	+$421K	﹤0.01%	452
2024 Q1	$167K	Buy	+919	New	+$158K	﹤0.01%	484

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Optiver Holding's ABBV Position: Q2 2026 in Review

Optiver Holding reduced its AbbVie (ABBV) stake by 85% in Q2 2026, selling an estimated $444K and leaving 370 shares worth $93.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Optiver Holding first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. The position peaked at $593K in Q2 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Optiver Holding held 370 shares of AbbVie worth $93.1K as of Q2 2026.
Optiver Holding sold 2,065 AbbVie shares in Q2 2026, an estimated $444K.
AbbVie made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1044 holding.
Optiver Holding first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
Optiver Holding's AbbVie position peaked at $593K in Q2 2024.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.